Dividend13 May 2026, 03:17 pm
GlaxoSmithKline Pharma Recommends ₹57 Dividend; Sets AGM Date
AI Summary
GlaxoSmithKline Pharmaceuticals Ltd's board has recommended a final dividend of ₹57 per equity share for FY26, subject to shareholder approval at the AGM. The AGM is scheduled for June 30, 2026, via video conferencing. The record date for determining dividend entitlement is May 29, 2026, with dividend payment on or after July 1, 2026. The company confirms it is not classified as a Large Corporate based on SEBI criteria. Audited financial results for the quarter and year ended March 31, 2026, were approved.
Key Highlights
- Final dividend of ₹57 per share recommended for FY26.
- AGM scheduled for June 30, 2026, via video conferencing.
- Record date for dividend entitlement is May 29, 2026.
- Dividend payment to be made on or after July 1, 2026.
- Company does not qualify as a Large Corporate as per SEBI circular.
Price Impact
More from GLAXO